Analystreport

Health Catalyst (NASDAQ: HCAT) had its price target lowered by analysts at Raymond James from $46.00 to $40.00. They now have a "strong-buy" rating on the stock.

Health Catalyst, Inc - Common stock  (HCAT) 
Last health catalyst, inc - common stock earnings: 2/27 04:05 pm Check Earnings Report